European Cancer Organisation’s Post

Ontada's commitment to support EOM data submission via mCODE standards. The U.S. healthcare systems can really benefit from reduction in administrative burden and accelerated time-to-insight with adoption of industry standards like FHIR/mCODE.

Finally, my first publication a systematic review of health literacy in cancer care #Socialdeterminantsofhealth #healthliteracy #cancer "Our awareness of health literacy and its association to Social Determinants of Health can enhance adherence to cancer treatment and lower the symptom burden" https://lnkd.in/dV3vgksh

Did you know that older adult cancer survivors can spend nearly 1 month out of the year receiving health care outside the home? Health care contact days—days spent receiving health care outside the home—are an important person-centered measure of time. This measure presents opportunities for recognizing and addressing patient burdens during cancer survivorship. We can do better. Check out the newest published study from our research team to learn more: https://lnkd.in/gXMvVPXP.  #CancerSurvivorship #HealthCare #umnproud

Ensuring the rights of people living with cancer requires a comprehensive approach that includes universal health coverage and national cancer control plans, informed by the principle of the right to health. Read this UICC article ahead of #WorldHealthDay: https://lnkd.in/eYdjihhe #MyHealthMyRight #UHC

𝐓𝐡𝐞 𝐊𝐢𝐧𝐠'𝐬 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬: 𝐀 𝐬𝐭𝐚𝐫𝐤 𝐫𝐞𝐦𝐢𝐧𝐝𝐞𝐫 𝐨𝐟 𝐭𝐡𝐞 𝐍𝐇𝐒'𝐬 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐢𝐧 𝐂𝐚𝐧𝐜𝐞𝐫 𝐜𝐚𝐫𝐞 The recent news of King Charles's cancer diagnosis, diagnosed incidentally during another procedure, shines a light on a significant issue: delays in timely cancer diagnosis and treatment within the NHS. While one in five cancers are discovered incidentally, many patients face extended wait times, exceeding the NHS target of 62 days. This is particularly concerning for "double hit" cases like the King's, where delays occur both before and after diagnosis. This raises critical questions about the NHS's capacity to meet the growing demand for cancer care. Factors like workforce shortages, lack of equipment, and long waiting lists contribute to these delays, causing stress and anxiety for patients. It's clear that the dedicated professionals working tirelessly within the NHS. However, systemic challenges hinder their ability to deliver optimal care. This situation prompts reflection: Are we adequately investing in the NHS infrastructure and personnel? Can we improve efficiency and reduce wait times for all patients, regardless of background? How can we support organisations like Macmillan Cancer Support further? #cancercare #NHS #healthcare #equity #investments

Conversation Openers - Practical Tips for Healthcare Professionals A short series quick and easy ‘bitesize’ videos (all under 10 mins) covering: - The emotional challenges of a rarer cancer for patients - How to integrate mental health and wellbeing into routine care - How to start conversations around mental health - Practical communication tips Access the Conversation Openers videos here: https://lnkd.in/ed7EhEsi Why have we made these videos? Conversation Openers, in partnership with Rareminds have been made in response to the 2022 Open Conversations report which highlighted a need for greater understanding of the psychological and emotional impact faced by neuroendocrine cancer (NC) patients and carers compared with the ‘common’ cancer population. The report recommended that healthcare professionals should hold open and ongoing conversations with their patients about neuroendocrine cancer and mental health and the Conversation Openers videos will support HCPs by providing practical communication tips on how they can have these open and ongoing conversations. NHS Cancer Research UK (CRUK)

Research presented by Katarina Vasiljevic, MD, University of California, San Diego, and colleagues at the 2024 ASCO Annual Meeting showed that standardizing electronic documentation of physician-led goals of care discussions in patients with cancer can lead to improved care integration across health care settings, ensuring comprehensive and individualized quality care for patients at the end of life. “Implementation of an initiative to standardize electronic documentation of GOC conversations improved early documentation of these vital conversations. Radiolabeling of the SmartPhrase made it easily accessible to all members of a patient’s care team,” said the researchers.  Read more about the study here: https://lnkd.in/ecmYAfSb #JournalOfClinicalPathways #ElectronicHealthRecprd #HealthTechnology #CancerCare #ValueBasedCare

At Qualify Health, we understand that facing a cancer diagnosis is one of life's toughest challenges. Not only does it test your strength and resilience, but it can also bring about unexpected financial burdens. That's why we're shining a light on the often-overlooked aspect of cancer care: financial toxicity. Did you know that cancer patients are 2 ½ times more likely to declare bankruptcy compared to those without the disease? It's a staggering statistic that highlights the urgent need for comprehensive financial support in the fight against cancer. Research from the Fred Hutchinson Cancer Center in Seattle reveals an even more alarming fact: those who declare bankruptcy are 80 percent more likely to succumb to the disease. Join Qualify Health in our mission to empower cancer patients and alleviate the burden of financial ruin. Together, we can turn the tide against cancer and ensure that every patient has the support they need to thrive. Visit us to know more: https://lnkd.in/dR2C4cMJ For Service call: + 1 864 650 6400 or, info@qualify.health #health #publichealth #qualify #copay #healthinsurance #healthcare #medicare #health #doctorvisit #insuranceclaim #medicalinsurance #medicalbilling #healthbenefits #baddebt #financialsupport #supportServices #CancerSupport #healthEquity #cancercosts #patientadvocacy #copayassistance #patientassistanceprograms #CopayAccumulator #HealthcareInnovation #PatientEmpowerment

On the heels of Kate Middleton’s announcement, Time health correspondent Jamie Ducharme explores possible reasons for the rise in cancer diagnoses among young adults citing a recent study that estimated early-onset diagnoses will increase by 30% by 2030. Colorectal, gastrointestinal, lung and early-onset breast cancer are those with the highest increase in incidence among young adults. Experts believe there is no single factor to blame but rather the combination of processed foods, not exercising enough, drinking too much alcohol, and rising obesity rates. Taking a preventive approach to health is the best way to protect your healthspan and finding a healthcare provider like those in our Biote network who will work with you holistically is a great first step. Read the full article here: #healthcare #future #longevity

Understanding the costs and benefits of investing in cancer Posted by: Brian Ferguson,  Posted on: 1 November 2016 -  Understanding the costs associated with cancer is vital in order that resources are used for maximum effect. And investing in prevention and early intervention is critical if we are going to reduce the emotional and physical impact of cancer on individuals, families, friends and those that care for people with cancer. Calculating the health care and wider costs of cancer - as well as assessing the cost-effectiveness of prevention, early intervention and treatment - is a fundamental challenge faced by decision makers across the health and social care system. The costs of cancer can be felt at an individual level: work by Macmillan has shown that most (83%) cancer patients incur an average cost of £570 per month as a result of their illness. It can also be felt in the national economy: Oxford University estimate the cost of cancer to the economy is £7.6 billion a year due to premature deaths and time taken off work. Costs and the health system The Independent Cancer Taskforce Report (ICTR) set out the need for there to be clearer accountability of spend on cancer and emphasised the need for action in prevention and early diagnosis to reduce the longer term burden on the health system. It says: “The National Audit Office has estimated cancer services cost the NHS approximately £6.7bn per annum in 2012/13. The Five Year Forward View projections indicate that this will grow by about 9% a year, implying a total of £13bn by 2020/21.” Recommendation 95 in the strategy specifically asks that: “NHS England and Public Health England should work with Monitor and other bodies to consider how to develop better health economic evaluation of new service models and interventions.” We have a dedicated health economics team that commissions work to assess the economic impact of prevention and early intervention, and an example of this is recent work on bowel cancer in direct response to Taskforce Recommendation 95. This work has summarised the available cost-effectiveness evidence. Cost-effectiveness is a key concept in health economics and is concerned with the value we get from the money spent – where value is often expressed in terms of improving both survival and quality of life. For instance if we invested resources in the best possible way in bowel cancer then we would see improvements in survival, and also improvements in the quality of life of individuals who are staged earlier and therefore do not suffer the more unpleasant effects of treatment that could potentially be avoided. This is why a ‘return on investment’ (RoI) type approach has been followed in this work: how do we make sure that resources are invested in such a way that we achieve health gains at the same time as avoiding health care and other system costs further down the line.